$XCUR
Exicure, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Chicago, IL
XCUR chart
What traders are saying about $XCUR
Latest postsExicure, Inc. news
- Exicure, Inc. Estimates – NASDAQ:XCUR
TradingView ·
- What Is Powering the Rally in Karyopharm Therapeutics, Estrella Immunopharma, CytoSorbents, MoonLake Immunotherapeutics, FibroBiologics, Exicure, Biohaven and Profusa Stocks Today, and What Should Investors Know About the Catalysts?
kalkine.ca ·
- Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
Yahoo Finance ·
- Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance
Yahoo Finance ·
- Exicure Announces Board and Committee Changes
Yahoo Finance ·
- Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
Yahoo Finance ·
- Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
Yahoo Finance ·
- Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Yahoo Finance ·
- Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
Yahoo Finance ·
- Exicure, Inc. Reports Full Year 2025 Financial Results
Yahoo Finance ·
- Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
Yahoo Finance ·
- Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Yahoo Finance ·
Exicure, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $500,000 | $0 | – |
| Net income | -$4.9M | -$9.7M | -$16.9M | -$2.6M |
| Diluted EPS | $-0.79 | $-4.75 | $-10.55 | $-0.56 |
| Total assets (year end) | $14.0M | $15.1M | $11.6M | $23.3M |
| Cash and equivalents (year end) | – | $12.5M | $816,000 | $8.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Exicure, Inc.
- Ticker
- XCUR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Chicago, IL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1698530
- Former names
- Max-1 Acquisition Corp
Frequently asked questions
What exchange is Exicure, Inc. listed on?
Exicure, Inc. trades on the Nasdaq under the ticker symbol XCUR.
What industry is Exicure, Inc. in?
Exicure, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Exicure, Inc. headquartered?
Exicure, Inc.'s business address on file with the SEC is in Chicago, IL.
When does Exicure, Inc.'s fiscal year end?
Exicure, Inc.'s fiscal year ends on December 31.
How much revenue did Exicure, Inc. report?
Exicure, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.